Solvias Opens Center of Excellence for Biologics and Cell & Gene Therapy in Research Triangle Park
MORRISVILLE, N.C., Jan. 27, 2025 /PRNewswire/ -- Solvias, a global provider of chemistry, manufacturing, and control (CMC) analytics, announced today the opening of its cutting-edge Center of Excellence for Biologics and Cell and Gene Therapy in the heart of Research Triangle Park (RTP), North Carolina. The new facility expands Solvias' global network of centers and reinforces its commitment to advancing transformative therapies for cancer and rare diseases.
Spanning 50,000 square feet, the new center is Solvias' flagship North American site for large molecule analytical services designed to accelerate the development and commercialization of innovative biologics. The facility will bring approximately 200 new jobs to the Raleigh-Durham area over the next three years and is being rolled out in two phases:
Phase 1: A 20,000-square-foot space for cGMP release testing—featuring cell-based potency and molecular assays—operational immediately.
Phase 2: An additional 30,000 square feet expected to open in July 2025, offering expanded capabilities for stability testing and advanced biophysical characterization.
Equipped with state-of-the art analytical instrumentation, laboratory automation, and advanced digital management systems, the new center offers comprehensive GMP testing for cell and gene therapies, monoclonal antibodies (mAbs), and other biologics, from preclinical stages to commercial release.
'This Center of Excellence in RTP is a milestone in Solvias' global growth journey,' said Archie Cullen, Chief Executive Officer of Solvias. 'Combining our team's expertise with advanced technology, we aim to set a new benchmark for delivering high-quality, reliable analytical support. It's an honor to partner with our clients in bringing groundbreaking therapies to patients worldwide.'
'We are focused on helping our clients succeed with our analytical expertise. We are hiring the best possible talent to be technical partners for our clients, helping them bring therapies to market faster and more efficiently. With this investment, we are committed to be an integral part of the US biopharma innovation ecosystem,' said Ilya Koltover, Chief Commercial Officer of Solvias.
Solvias' new center expands its global footprint to six centers of excellence and marks the company's second site in North America. For more information on Solvias' new Center of Excellence in RTP, visit solvias.com.
About Solvias
Solvias is a global provider of chemistry, manufacturing, and control (CMC) analytics to the life sciences industry. Its expert team combines decades of experience with regulatory expertise across small molecules, biologics, and cell and gene therapies. Solvias offers end-to-end solutions from raw material testing to drug product release and API development for small molecules. Headquartered near Basel, Switzerland, Solvias operates six global Centers of Excellence, all adhering to the highest ISO, GMP, GLP, and FDA standards. For more information, visit solvias.com.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
15 minutes ago
- Yahoo
ClearPoint Neuro, Inc. (CLPT): A Bull Case Theory
We came across a bullish thesis on ClearPoint Neuro, Inc. (CLPT) on M.V. Cunha's Substack. In this article, we will summarize the bulls' thesis on CLPT. ClearPoint Neuro, Inc. (CLPT)'s share was trading at $13.93 as of 6th June. A medical doctor surrounded by advanced technology in the operating room. ClearPoint Neuro is transforming from a surgical tools provider into a critical platform company enabling the next generation of neurological treatments. In the first quarter of 2025, revenue grew 31 percent year-over-year to 8.5 million dollars, led by the rapid adoption of its SmartFrame operating room system, which increased 70 percent and allows hospitals to use ClearPoint technology in standard surgical settings. This expansion seeds a larger installed base and drives high-margin recurring revenue from disposable instruments. The biologics and drug delivery segment generated 4.7 million dollars in revenue, growing 9 percent year-over-year, and is supported by more than 60 active partnerships with gene and cell therapy developers. As these therapies move toward commercial use, ClearPoint's role as the enabling delivery infrastructure could become its most profitable revenue stream, with each procedure generating over 20,000 dollars in high-margin recurring revenue. Meanwhile, the company is intentionally moving away from capital equipment sales, which declined 63 percent, in favor of a subscription-based model that provides predictable recurring revenue. Operating cash burn fell 35 percent in 2024, with expenses rising 29 percent in the latest quarter due to targeted investments in preclinical services, therapy support, and device innovation. ClearPoint closed the quarter with 12.4 million dollars in cash and access to up to 105 million dollars in financing, providing sufficient capital to reach financial breakeven without near-term equity dilution. While risks around execution, partner dependency, and regulatory pacing remain, ClearPoint's embedded position across neurological therapy development offers investors a unique opportunity to benefit from a long-term transformation into the backbone of next-generation brain treatments. Previously, we highlighted a on ClearPoint Neuro from northeasternsvf in January 2025, which emphasized its unique position as the only FDA-cleared, MRI-guided neurosurgical platform enabling precise delivery of CNS gene and cell therapies. That thesis focused on the company's expanding biopharma partnerships, operating room penetration through SmartFrame OR, and its path to profitability via high-margin disposables. ClearPoint Neuro, Inc. (CLPT) is not on our list of the 30 Most Popular Stocks Among Hedge Funds. As per our database, 21 hedge fund portfolios held CLPT at the end of the first quarter which was 13 in the previous quarter. While we acknowledge the risk and potential of CLPT as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns, and doing so within a shorter timeframe. If you are looking for an AI stock that is more promising than CLPT but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock. READ NEXT: 8 Best Wide Moat Stocks to Buy Now and 30 Most Important AI Stocks According to BlackRock. Disclosure: None. This article was originally published at Insider Monkey.
Yahoo
20 minutes ago
- Yahoo
Kashgar Completes Xinjiang's First 10-GW Photovoltaic Base
Construction of Southern Xinjiang's New Power System Demonstration Zone Enters New Phase KASHGAR, China, June 11, 2025 /PRNewswire/ -- On May 30, with the full-capacity grid connection of projects like the Huadian Kashgar Jiashi 300 MW Ecological Management Integrated Photovoltaic Power Station, the installed photovoltaic capacity in Kashgar reached a historic milestone of 10.242 GW, accounting for 75.7% of Kashgar's total power capacity. This marks the completion of Xinjiang's first 10-GW-level all-photovoltaic base, signifying a major breakthrough in Kashgar's new energy development and serving as a landmark achievement in building Southern Xinjiang's new power system demonstration zone. Located on the western edge of the Taklimakan Desert, Kashgar enjoys over 2,800 hours of annual sunshine and vast expanses of desert and Gobi land, providing natural advantages for constructing ultra-large-scale photovoltaic bases. The region's exploitable photovoltaic potential is estimated at 200 GW, with 22.24 GW already approved. In recent years, guided by China's "dual carbon" goals and Xinjiang's new energy system plan, Kashgar has accelerated large-scale new energy development, targeting "gigawatt-level projects at the county level and 10-gigawatt-level projects at the prefecture level." State Grid Kashgar Power Supply Company has innovatively launched a "one-stop" service for the entire new energy grid connection process. By establishing flexible teams and opening green channels, it efficiently resolves challenges such as project land use and grid access. In 2024, 14.6 GW of registered photovoltaic projects are accelerating their implementation, reflecting an "explosive growth" trend in Kashgar's new energy sector. To address the grid absorption pressure from surging photovoltaic capacity, Kashgar's power grid has focused on "strengthening backbone infrastructure and optimizing dispatching" to build a new power system support framework. A 7.8-billion-yuan investment is advancing the Kashgar 750 kV double-ring grid reinforcement project, which will enhance power supply capacity by 5 GW upon completion. An integrated "hydro-PV-storage" smart dispatching platform has been established, utilizing multi-objective flexible load control technology to achieve precise matching between new energy generation, high-load industries, and energy storage facilities. To tackle the challenges of high-penetration renewable integration, Kashgar has pioneered a coordinated "source-grid-load-storage" development model. Peak-shaving through energy storage is advancing on multiple fronts: a 200 MW electrochemical independent energy storage system was completed in 2024, while the 1.4 GW Tashkurgan pumped hydro project progresses, alongside pilot grid-forming energy storage projects—boosting system regulation capacity by 30%. Multi-energy complementarity optimizes structure: leveraging the Yarkant River's "one reservoir, six cascades" hydropower and the 1.4 GW pumped storage project, a "hydro-PV-thermal-storage" integrated system enables flexible operation—photovoltaic supplementation during dry seasons and hydropower peak-shaving during wet seasons. Digitalization empowers the smart grid: a new smart dispatching control system enables online monitoring and AI-driven decision-making, achieving coordinated "PV-storage" operation and second-level fault response, steadily enhancing grid stability. Simultaneously, Kashgar is securing specialized investments for six key areas: photovoltaic desert-control ecological projects, border microgrid demonstrations, high-load industry absorption, and international energy cooperation. It explores new ecological models like "power generation atop panels, sand fixation beneath panels," promotes "PV-storage microgrids" in remote border areas to benefit residents, and attracts industries like steel smelting and green hydrogen production—transforming resource advantages into economic gains. Kashgar is evolving from the "Pearl of the Silk Road" into the "Central Asian Photovoltaic Valley," injecting new momentum into building a green energy corridor for the Belt and Road Initiative. View original content: SOURCE State Grid Kashgar Power Supply Company Sign in to access your portfolio
Yahoo
30 minutes ago
- Yahoo
Joan Schwartz releases 'Divine Healing: Ancient Secrets of Our Ancestors'
New book bridges science and spirituality with the Integrated Healing Dynamics Method for self-guided mind-body-spirit healing RIVERTON, Utah, June 11, 2025 /PRNewswire-PRWeb/ -- First-time author Joan Schwartz marks her entry into publishing with the release of "Divine Healing: Ancient Secrets of Our Ancestors" (published by Balboa Press). Blending ancient spiritual insight with contemporary scientific understanding, this book introduces the Integrated Healing Dynamics (IHD) Method — a holistic, accessible healing framework designed to awaken the innate power within every individual. Rooted in a vision that first appeared to her in 1988, Schwartz says the inspiration for "Divine Healing" came through higher guidance. "I had a revelation and saw the book from beginning to end," she recalls. "Later, I was given direction to write a healing book so that if people couldn't get a session or help from me, they could heal themselves." "Divine Healing: Ancient Secrets of Our Ancestors" is a complete healer's resource that empowers readers with the knowledge and techniques to realign their energy, awaken their body's natural healing systems, and cultivate peace, joy, and self-love. The IHD Method taught in the book is the culmination of a lifetime of spiritual dialogue and deep intuitive knowing. Through its simple, step-by-step exercises and guiding principles, readers are invited to remove the "mask" that blocks them from their true essence — and step into their divine right to healing. "Healing is not just about the body; it is about the mind and spirit too," the author reminds. From relieving physical pain to addressing emotional wounds and spiritual imbalances, "Divine Healing: Ancient Secrets of Our Ancestors" offers a practical roadmap to transformation. To get a copy and learn more, visit "Divine Healing: Ancient Secrets of Our Ancestors" By Joan Schwartz Hardcover | 6 x 9in | 836 pages | ISBN 9798765255186 Softcover | 6 x 9in | 836 pages | ISBN 9798765255162 E-Book | 836 pages | ISBN 9798765255179 Available at Amazon and Barnes & Noble About the Author Joan Schwartz is a seasoned hypnotherapist and integrative healer with decades of experience in energy work, clinical hypnotherapy, and alternative healing. Her journey began in childhood with a deep sensitivity to unseen energies and was shaped by transformative life events, including a pivotal car accident in 1965 and a near-fatal brain hemorrhage. With a Ph.D. in Alternative Healing, Clinical Hypnotherapy and Philosophy, Schwartz blends science and spirituality to empower others in unlocking their healing potential. She is passionate about helping individuals live peaceful, fulfilling lives through self-discovery and holistic healing practices. Balboa Press, a division of Hay House, Inc. – a leading provider in publishing products that specialize in self-help and the mind, body, and spirit genres. Through an alliance with the worldwide self-publishing leader Author Solutions, LLC, authors benefit from the leadership of Hay House Publishing and the speed-to-market advantages of the self-publishing model. For more information, visit To start publishing your book with Balboa Press, call 844-682-1282 today. Media Contact Marketing Services, BalboaPress, 844-682-1282, pressreleases@ View original content to download multimedia: SOURCE BalboaPress
